Works matching IS 15228517 AND DT 2010 AND VI 12 AND IP 5

Results: 14

FasL gene knock-down therapy enhances the antiglioma immune response.

Published in:

Neuro-Oncology, 2010, v. 12, n. 5, p. 482

By:

Jansen, Timothy;
Tyler, Betty;
Mankowski, Joseph L.;
Recinos, Violette Renard;
Pradilla, Gustavo;
Legnani, Federico;
Laterra, John;
Olivi, Alessandro

Publication type:

Article

Human umbilical cord blood stem cells show PDGF-D–dependent glioma cell tropism in vitro and in vivo.

Published in:

Neuro-Oncology, 2010, v. 12, n. 5, p. 453

By:

Gondi, Christopher S.;
Veeravalli, Krishna Kumar;
Gorantla, Bharathi;
Dinh, Dzung H.;
Fassett, Dan;
Klopfenstein, Jeffrey D.;
Gujrati, Meena;
Rao, Jasti S.

Publication type:

Article

Infiltrative patterns of glioblastoma spread detected via diffusion MRI after treatment with cediranib.

Published in:

Neuro-Oncology, 2010, v. 12, n. 5, p. 466

By:

Gerstner, Elizabeth R.;
Chen, Poe-Jou;
Wen, Patrick Y.;
Jain, Rakesh K.;
Batchelor, Tracy T.;
Sorensen, Gregory

Publication type:

Article

Chloroquine-induced autophagic vacuole accumulation and cell death in glioma cells is p53 independent.

Published in:

Neuro-Oncology, 2010, v. 12, n. 5, p. 473

By:

Geng, Ying;
Kohli, Latika;
Klocke, Barbara J.;
Roth, Kevin A.

Publication type:

Article

Akt signaling pathway: a target for radiosensitizing human malignant glioma.

Published in:

Neuro-Oncology, 2010, v. 12, n. 5, p. 434

By:

Chautard, Emmanuel;
Loubeau, Gaëlle;
Tchirkov, Andreï;
Chassagne, Jacques;
Vermot-Desroches, Claudine;
Morel, Laurent;
Verrelle, Pierre

Publication type:

Article

Genetic variants in inflammation pathway genes and asthma in glioma susceptibility.

Published in:

Neuro-Oncology, 2010, v. 12, n. 5, p. 444

By:

Amirian, E.;
Liu, Yanhong;
Scheurer, Michael E.;
El-Zein, Randa;
Gilbert, Mark R.;
Bondy, Melissa L.

Publication type:

Article

Loss of 1p, 19q, and 10q heterozygosity prospectively predicts prognosis of oligodendroglial tumors—towards individualized tumor treatment?

Published in:

Neuro-Oncology, 2010, v. 12, n. 5, p. 490

By:

Ramirez, Carole;
Bowman, Clive;
Maurage, Claude-Alain;
Dubois, François;
Blond, Serge;
Porchet, Nicole;
Escande, Fabienne

Publication type:

Article

Society news.

Published in:: Neuro-Oncology, 2010, v. 12, n. 5, p. 517
Publication type:: Article

Editorial Board.

Published in:: Neuro-Oncology, 2010, v. 12, n. 5, p. NP, doi. 10.1093/neuonc/noq060
Publication type:: Article

Subscription Page.

Published in:: Neuro-Oncology, 2010, v. 12, n. 5, p. NP, doi. 10.1093/neuonc/noq061
Publication type:: Article

p53 in malignant glioma: 20 years later and still much to learn.

Published in:

Neuro-Oncology, 2010, v. 12, n. 5, p. 421

By:

James, C. David

Publication type:

Article

A phase II trial of primary temozolomide in patients with grade III oligodendroglial brain tumors.

Published in:

Neuro-Oncology, 2010, v. 12, n. 5, p. 500

By:

Gan, Hui K.;
Rosenthal, Mark A.;
Dowling, Anthony;
Kalnins, Renate;
Algar, Elizabeth;
Wong, Nicholas;
Benson, Angela;
Woods, Anne-Marie;
Cher, Lawrence

Publication type:

Article

Gliomas display a microRNA expression profile reminiscent of neural precursor cells.

Published in:

Neuro-Oncology, 2010, v. 12, n. 5, p. 422, doi. 10.1093/neuonc/nop061

By:

Lavon, Iris;
Zrihan, Daniel;
Granit, Avital;
Einstein, Ofira;
Fainstein, Nina;
Cohen, Malkiel A.;
Cohen, Mikhal A.;
Zelikovitch, Bracha;
Shoshan, Yigal;
Spektor, Sergei;
Reubinoff, Benjamin E.;
Felig, Yakov;
Gerlitz, Offer;
Ben-Hur, Tamir;
Smith, Yohav;
Siegal, Tali

Publication type:

Article

Cetuximab, bevacizumab, and irinotecan for patients with primary glioblastoma and progression after radiation therapy and temozolomide: a phase II trial.

Published in:

Neuro-Oncology, 2010, v. 12, n. 5, p. 508

By:

Hasselbalch, Benedikte;
Lassen, Ulrik;
Hansen, Steinbjørn;
Holmberg, Mats;
Sørensen, Morten;
Kosteljanetz, Michael;
Broholm, Helle;
Stockhausen, Marie-Thérése;
Poulsen, Hans Skovgaard

Publication type:

Article